# The Multiple Dose of PK/PD Study of SHR2285 Tablets in Healthy Subjects

> **NCT04229433** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Thrombus

## Interventions

- **DRUG:** SHR2285 tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04229433
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-11
- **Primary completion:** 2020-11-08
- **Final completion:** 2020-11-08
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04229433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04229433, "The Multiple Dose of PK/PD Study of SHR2285 Tablets in Healthy Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04229433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*